ACSL3 and neoplasm: Indeed, we showed that inhibition of acyl-CoA synthetase long chain 3 (ACSL3), an enzyme that activates extracellularly-derived fatty acids by adding a CoA moiety, delayed tumor growth, suppressed fibrosis, and enhanced the activation and abundance of CD8+ T cells in KPC mice [139].